BLS Polymers
FinMinutes Deep Business Model & Edge
BLS Polymers Limited is engaged in manufacturing custom formulated polymer compounds catering to critical industries such as telecommunication, power, railways, water, and oil & gas distribution.
What this company actually does — full breakdown ▾
Incorporated in 1991, BLS Polymers Limited manufactures multiple grades of custom formulated polymer compounds, including HDPE, MDPE, LLDPE, XLPE, HFFR, PVC, cable filling compounds, and adhesive coating compounds. It operates a manufacturing facility in Goa equipped with eleven production lines and also engages in trading polymer resins.
- Polymer Division — Manufacturing of polymer compounds including PE, XLPE, PVC, HFFR, and cable filling compounds.
- Trading Division — Procurement and supply of various grades of HDPE resin and LLDPE resin.
Enlisted product portfolio with prominent government agencies and CPSEs (Maharatna, Navratna, and Miniratna), multi-grade compounding capabilities (127 grades), long-standing customer relationships, and integrated quality control infrastructure.
The Offer
Follow the Money — Use of Proceeds
- Financing the capital expenditure requirement towards expansion of our Manufacturing Facility by increasing the manufacturing capacity of certain of our existing products — ₹77.56 cr
- Funding working capital requirements of our Company — ₹89.50 cr
- General Corporate Purposes
Valuation at the Offer Price
The filing does not print a single headline multiple, so this one is ours: the upper band divided by the latest restated earnings per share — the same arithmetic the “Basis for the Offer Price” section performs. It is struck on pre-issue earnings; where the issue creates new shares, the post-issue multiple is computed in the workings below. The peer group is the one the filing itself names. A premium is not the same thing as expensive and a discount is not the same thing as cheap — the peer table and the reasons sit further down this page.
FinMinutes IPO Score — How It's Built
Transparent, deterministic, computed from the filing — not an opinion. Open any component below to see exactly what it measures and what it is worth. Components with no disclosed input are dropped from the weighting entirely rather than held at an invented neutral, because a constant inside a weighted average is not neutral — it quietly drags every score toward the middle. Weighted across 4 live components.
88% of the designed weighting had real data behind it on this issue. Not yet scored here: Filing Integrity. A lower coverage figure does not mean a worse company — it means we are standing behind less of the picture, and you should read the findings below rather than the headline number.
How this is measured12%
Whether fresh capital actually enters the business. A predominantly offer-for-sale issue is marked down ONLY when the financials are weak. A profitable, cash-rich company selling down is treated as neutral, not penalised, because it does not need the money.
How this is measured32%
Driven by the models battery run on the filing's own restated numbers: the Piotroski fundamental tests (scored out of those we could actually run), the Altman Z-double-prime solvency zone, and the direction of profit across the disclosed period. It is not a single yes/no on last year's profit.
How this is measured10%
The post-issue earnings multiple against the peer median disclosed in the filing. A discount to the median scores well and a premium scores badly. When the filing does not disclose comparable peer multiples, this component is dropped from the weighting rather than held at a made-up neutral.
How this is measured28%
Starts at 100 and loses points for every material finding: 12 for a flagged finding, 4 for a noted one. Two kinds feed it. DERIVED findings are computed from the filed numbers against stated thresholds — operating cash negative while profit is positive, related-party revenue above 15% of total, revenue rising while profit falls, goodwill above 30% of net worth, receivables growing more than 1.3x faster than sales, cash below half of short-term debt. Those are reproducible: the same filing gives the same answer every time, and the rule is printed beside the finding. READ findings come from the forensic sweep of the notes. Contingent liabilities, related-party intensity, customer concentration, litigation, auditor qualifications, statutory dues, promoter funding. Findings that record the ABSENCE of a problem — no litigation pending, an unmodified audit opinion — deduct nothing. This is the component our forensic read drives directly, and it moves most between companies.
3-Year Financial & Growth Trend
| Metric | FY26 | FY25 | FY24 |
|---|---|---|---|
| Revenue (₹ Cr) | 349.4283 | 328.4359 | 296.3583 |
| Net Profit (₹ Cr) | 27.0094 | 21.136 | 7.522 |
| PAT Margin | 7.73% | 6.44% | 2.54% |
Revenue Breakdown
- Wire and Cables: 80.93%
- Industrial Pipelines: 19.07%
Why the numbers moved, in management’s own words
Taken from the Management’s Discussion and Analysis section of the filing. A number tells you what happened; this is the company’s explanation of why, and whether it calls the cause temporary or structural.
| Metric | Move | Management's stated reason | Type |
|---|---|---|---|
| Revenue from Operations (FY25 to FY26) | ↑ 6.4% | Increased sales volume in core wire & cable polymer compounds and growth in polymer trading division | Structural |
| Profit After Tax (PAT) (FY25 to FY26) | ↑ 27.8% | Higher gross margins, operating efficiencies, and optimization of raw material procurement costs | Structural |
Headwinds
- Raw material price volatility (polyethylene resins LLDPE/HDPE) sector persistent
Company mitigates fluctuations through prompt procurement, advance customer order pricing, and long-standing supplier relationships - Customer concentration (top 10 customers account for ~66.81% of revenue) company persistent
Working on diversifying customer base and entering new geographical markets
Tailwinds
- Expanding domestic wire & cable and gas pipeline infrastructure (5G rollout, National Gas Grid, Jal Jeevan Mission) sector
Drives sustained demand for specialized 3LPE pipe coating and cable compounds
| Facility | Period | Utilisation |
|---|---|---|
| Goa Manufacturing Facility - PE Compounds | FY26 | 75.3% |
| Goa Manufacturing Facility - XLPE Compounds | FY26 | 73.2% |
| Goa Manufacturing Facility - PVC Compounds | FY26 | 11.8% |
| Goa Manufacturing Facility - Overall Total | FY26 | 66.0% |
Issue Timeline
Dates as carried by the exchange feed. Allotment, refund and credit dates move more often than the open and close dates do.
- Refunds initiated2026-11-02
- Pre Application Start2026-10-23
- Bidding Start2026-10-27
- Bidding End2026-10-29
- Allotment Process Start2026-10-30
- Allotment Finalization2026-11-02
- Listing Day2026-11-03
- Mandate End2026-12-10
Applying, and Who Handles the Allotment
Check allotment status on the registrar’s own portal → We link the registrar directly rather than mirroring the form.
Deep Financials
Revenue, EBITDA and profit are what every listing site prints. Below are the full restated statements as disclosed, the ratios we compute from them, and a DuPont decomposition of the return on equity. A prospectus carries three years, not ten — that is the document’s ceiling, and within it we go as deep as it allows.
Income StatementThe profit and loss as filed, then what we derive from it — kept apart.
Statutory order, exactly as restated in the filing. Finance cost and depreciation sit inside Total Expenses under Ind AS, which is why they are listed among the expense lines here rather than below the total. The expense rows sum to the total. Rows the filing does not disclose separately are omitted rather than left blank.
| Income Statement — as filed (₹ Cr) | FY26 | FY25 | FY24 |
|---|---|---|---|
| Revenue from Operations | 349.43 | 328.44 | 296.36 |
| Other Income | 4.98 | 8.26 | 5.15 |
| Total Income | 354.41 | 336.70 | 301.50 |
| Cost of Materials Consumed | 169.97 | 189.32 | 209.94 |
| Purchases of Stock-in-Trade | 109.22 | 76.60 | 40.97 |
| Changes in Inventories | -6.17 | -0.39 | -2.27 |
| Employee Benefit Expense | 8.49 | 7.15 | 7.24 |
| Finance Cost | 8.02 | 8.68 | 9.15 |
| Depreciation & Amortisation | 2.88 | 3.07 | 2.71 |
| Other Expenses | 26.02 | 23.98 | 24.07 |
| Total Expenses | 318.43 | 308.43 | 291.81 |
| Profit Before Exceptional Items and Tax | 35.99 | 28.27 | 9.69 |
| Profit Before Tax | 35.99 | 28.27 | 9.69 |
| Tax Expense | 8.98 | 7.13 | 2.17 |
| Profit After Tax | 27.01 | 21.14 | 7.52 |
| Other Comprehensive Income | -0.02 | -0.02 | 0.05 |
| Total Comprehensive Income | 26.99 | 21.11 | 7.57 |
| EPS - Basic | 5.99 | 4.69 | 1.67 |
| EPS - Diluted | 5.99 | 4.69 | 1.67 |
Balance SheetWhat the company owns, owes, and is worth on paper.
| Balance Sheet (₹ Cr) | FY26 | FY25 | FY24 |
|---|---|---|---|
| Share Capital | 45.03 | 9.60 | 9.60 |
| Reserves & Surplus | 49.90 | 58.34 | 37.23 |
| Net Worth | 94.93 | 67.94 | 46.83 |
| Long-term Borrowings | 2.84 | 0.66 | 3.00 |
| Short-term Borrowings | 48.87 | 73.26 | 90.76 |
| Total Borrowings | 51.72 | 73.92 | 93.77 |
| Trade Payables | 49.20 | 27.47 | 19.98 |
| Current Liabilities | 106.78 | 109.13 | 116.72 |
| Total Liabilities | 111.20 | 111.20 | 121.66 |
| Property, Plant & Equipment | 22.51 | 19.87 | 21.22 |
| Capital Work in Progress | 1.74 | — | — |
| Intangible Assets | — | — | 0.02 |
| Inventories | 72.59 | 54.62 | 62.44 |
| Trade Receivables | 72.71 | 73.73 | 62.69 |
| Cash & Equivalents | 0.67 | 0.01 | 0.02 |
| Current Assets | 177.32 | 157.35 | 146.84 |
| Total Assets | 206.13 | 179.14 | 168.49 |
Cash FlowWhere the cash actually went. Often the most honest statement of the three.
| Cash Flow (₹ Cr) | FY26 | FY25 | FY24 |
|---|---|---|---|
| Net Cash from Operating Activities | 38.06 | 25.13 | 2.65 |
| Capital Expenditure | 4.73 | 2.75 | 2.85 |
| Net Cash from Investing Activities | -6.36 | 0.58 | -0.72 |
| Net Cash from Financing Activities | -31.05 | -25.72 | -2.24 |
| Net Change in Cash | 0.66 | -0.01 | -0.31 |
Ratio AnalysisProfitability, leverage, liquidity, efficiency and earnings quality — computed by us.
Every ratio below is computed by us from the line items the company disclosed — not copied from anywhere. The arithmetic is standard; the point is that somebody actually did it. Blank cells mean the filing did not disclose the inputs, and we would rather show a gap than invent a number.
| Ratio | FY26 | FY25 | FY24 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin (%) | 13.2 | 11.9 | 7.1 |
| EBIT Margin (%) | 12.4 | 11 | 6.3 |
| PAT Margin (%) | 7.7 | 6.4 | 2.5 |
| Return on Equity (%) | 28.5 | 31.1 | 16.1 |
| Return on Capital Employed (%) | 30 | 26 | 13.4 |
| Return on Assets (%) | 13.1 | 11.8 | 4.5 |
| Leverage | |||
| Debt / Equity (x) | 0.54 | 1.09 | 2 |
| Net Debt / EBITDA (x) | 1.09 | 1.85 | 4.35 |
| Interest Coverage (x) | 5.49 | 4.26 | 2.06 |
| Liquidity | |||
| Current Ratio (x) | 1.66 | 1.44 | 1.26 |
| Quick Ratio (x) | 0.98 | 0.94 | 0.72 |
| Efficiency | |||
| Asset Turnover (x) | 1.7 | 1.83 | 1.76 |
| Receivable Days | 76 | 82 | 77 |
| Inventory Days | 97 | 75 | 92 |
| Payable Days | 66 | 38 | 29 |
| Cash Conversion Cycle (days) | 107 | 119 | 140 |
| Quality of Earnings | |||
| Operating Cash Flow / PAT (x) | 1.41 | 1.19 | 0.35 |
| Accruals Ratio (%) | -5.4 | -2.2 | 2.9 |
| Capex / Depreciation (x) | 1.64 | 0.89 | 1.05 |
| Inventory and payable days are measured against cost of goods (materials consumed + purchases of stock-in-trade + change in inventories). Receivable days against revenue. | |||
DuPont DecompositionWhy the return on equity is what it is: margin, efficiency, or leverage.
A headline return on equity tells you what. The DuPont decomposition tells you why — whether the return is earned through margin, through asset efficiency, or simply through leverage. Two companies can post an identical ROE for opposite reasons, and only one of them is safe.
| Component | FY26 | FY25 | FY24 |
|---|---|---|---|
| Net Margin (PAT / Revenue) | 7.7% | 6.4% | 2.5% |
| Asset Turnover (Revenue / Assets) | 1.7x | 1.83x | 1.76x |
| Equity Multiplier (Assets / Net Worth) | 2.17x | 2.64x | 3.6x |
| = Return on Equity | 28.5% | 31.1% | 16.1% |
| Tax Burden (PAT / PBT) | 0.75x | 0.75x | 0.78x |
| Interest Burden (PBT / EBIT) | 0.82x | 0.77x | 0.51x |
| Operating Margin (EBIT / Revenue) | 12.6% | 11.3% | 6.4% |
Computed from the disclosed statements. Where the filing omits an input, the row is left blank rather than estimated.
Quality of EarningsWhat the statements say when you read them against each other.
What the statements say once you read them against each other. These are observations, not verdicts — every one is arithmetic on the numbers the company itself disclosed, and each is stated so you can go and check it in the filing.
- Operating cash flow was 1.41x reported profit in FY26. Earnings are converting into cash, which is what you want to see and frequently is not the case.
- Between FY24 and FY26 revenue grew 18% while profit grew 259%. Profit expanding at several times the rate of revenue is not automatically a concern — operating leverage does exactly this — but it is worth confirming from the filing whether the gap comes from genuine margin expansion or from one-off items.
Forensic ModelsBeneish, Altman, Piotroski and the Montier C-score — plus our own final-year check.
Beneish M-Score
7 of 8 inputsAn eight-variable model built to detect earnings manipulation, and built to run on exactly two consecutive years — which is what a prospectus gives us. It belongs here more than anywhere: a company about to list has the maximum possible incentive to have dressed up the very years it is about to show you. A score above −1.78 is the threshold at which the model says the accounts merit a closer look. It is a screening signal, not an accusation, and it was calibrated on listed companies elsewhere. Read the eight components, not just the total.
| Component | Value | What it captures |
|---|---|---|
| DSRI Days Sales in Receivables Index (Receivables_t / Sales_t) / (Receivables_t-1 / Sales_t-1) | 0.927 | Above 1 means receivables grew faster than sales. Revenue may be being recognised ahead of collection. |
| GMI Gross Margin Index GrossMargin_t-1 / GrossMargin_t | 0.825 | Above 1 means margins deteriorated. A firm with worsening prospects has more incentive to manipulate. |
| AQI Asset Quality Index AQ_t / AQ_t-1, where AQ = 1 - (CurrentAssets + PPE) / TotalAssets | — | Above 1 means a rising share of assets is soft (neither current nor fixed) — capitalised costs can hide here. |
| SGI Sales Growth Index Sales_t / Sales_t-1 | 1.064 | Growth is not manipulation. But high-growth firms face more pressure to keep the streak going. |
| DEPI Depreciation Index DepRate_t-1 / DepRate_t, where DepRate = Dep / (Dep + PPE) | 1.182 | Above 1 means assets are being depreciated more slowly — a quiet way to lift reported profit. |
| SGAI SG&A Index (SGA_t / Sales_t) / (SGA_t-1 / Sales_t-1), SGA proxied as employee cost + other expenses | 1.042 | A proxy, because filings rarely break out SG&A cleanly. Read it as a direction, not a precise figure. |
| LVGI Leverage Index Leverage_t / Leverage_t-1, where Leverage = (CurrentLiab + LongTermDebt) / TotalAssets | 0.868 | Above 1 means leverage rose. Debt covenants create pressure to hit numbers. |
| TATA Total Accruals to Total Assets (PAT - CashFromOperations) / TotalAssets | -0.0536 | The gap between reported profit and cash generated. The single heaviest term in the model — and the one that catches profit that never became cash. |
The filing does not disclose every input the model needs, so we withhold the composite score rather than substitute a guess. The components we could compute are above.
Altman Z″-Score (emerging markets)
Z″ = 8.62 · SafeA distress-prediction model. We use the Z″ variant deliberately: the original Z was calibrated on American manufacturers and misleads badly on Indian services companies. Above 2.6 is the safe zone, 1.1 to 2.6 is grey, below 1.1 is the distress zone. Like every model of its kind it is a screen, not a prophecy.
| X1 — Working Capital / Total Assets | 0.342 |
| X2 — Reserves / Total Assets | 0.242 |
| X3 — EBIT / Total Assets | 0.213 |
| X4 — Net Worth / Total Liabilities | 0.854 |
| Z″ = 3.25 + 6.56·X1 + 3.26·X2 + 6.72·X3 + 1.05·X4 | 8.62 |
X2 is meant to read retained earnings. The filing reports Other Equity, which also holds securities premium paid in by investors, so X2 here runs on reserves and reads higher than true retained earnings would. The more premium the company has raised before listing, the more Z″ is flattered.
Piotroski F-Score (adapted)
6 / 8Nine yes-or-no tests of fundamental strength — except we run eight. One of the original nine asks whether the company issued new shares, which is plainly absurd to ask of a company whose entire purpose at this moment is to issue shares. We drop that test, and we would rather tell you that than quietly fudge it.
- ✓Positive return on assets
- ✓Positive operating cash flow
- ✓Return on assets improving
- ✓Cash flow exceeds profit (quality of earnings)
- ✗Long-term leverage decreasing
- ✓Current ratio improving
- ✓Gross margin improving
- ✗Asset turnover improving
Montier C-Score
4 of 6 signsSix yes-or-no signs that reported profit may be running ahead of the business, from James Montier’s 2008 screen, read here for FY26 against FY25. Each is a direction in the statements, not a judgement. Several together are a reason to read the accounting policies and notes closely; none on its own means anything is wrong, and growing companies trip some of them honestly.
- ○Gap between profit and operating cash flow widening · PAT − CFO: ₹-4.0 cr in FY25, ₹-11.1 cr in FY26
- ○Receivable days rising · 82 days in FY25, 76 days in FY26
- ●Inventory days rising · 75 days in FY25, 97 days in FY26 (on cost of goods)
- ●Other current assets rising against revenue · 8.8% of revenue in FY25, 9.0% in FY26 (current assets less cash, receivables and inventory)
- ●Depreciation falling against fixed assets · 15.5% of net block in FY25, 12.8% in FY26
- ●Total assets growing more than 10% a year · 15.1% in FY26
Ratios Nobody Prints
- Contingent liabilities / Net worth: 0.8%
Contingent liabilities of 0.78 cr against a net worth of 94.93 cr — 0.8% of what the company is worth on paper. These are obligations that sit off the balance sheet but could land on it. What they consist of matters as much as the size: a corporate guarantee to a subsidiary is a different animal from a disputed tax demand, and the filing says which. - Cash / Short-term borrowings: 0.01x
Short-term borrowings of 48.87 cr against cash of 0.67 cr. Debt that must be refinanced within a year is only comfortable while lenders stay comfortable. - Promoter remuneration / PAT: 0.9%
Managerial remuneration to the promoter group was 0.24 cr against a profit of 27.01 cr. This is a legitimate cost — but it is also a route by which value leaves a company before it ever reaches a minority shareholder.
What the Price RequiresThe profit the offer price needs, at three hurdle rates. A restatement of the price, not a view on it.
At the upper band of ₹150.00, the market value is ₹930 cr. A buyer who wants a given return each year from a business that never grows needs annual profit of market value × that return. The three rates are round hurdle rates, not this company’s cost of capital, so pick the one that is yours. The years columns assume profit compounds from the FY26 figure and the price stands still. None of this is a forecast, a fair value or a target.
| Hurdle rate | Profit the price needs | × FY26 profit | Years at 15% growth | Years at 25% growth |
|---|---|---|---|---|
| 10% a year | ₹93.0 cr | 3.4x | 8.9 | 5.5 |
| 12% a year | ₹112 cr | 4.1x | 10.2 | 6.4 |
| 14% a year | ₹130 cr | 4.8x | 11.3 | 7.1 |
- Earnings yield at the upper band: 2.90% (FY26 profit ÷ market value).
- Free cash flow yield: 3.58% (operating cash flow less capital expenditure, ₹33.3 cr, ÷ market value).
The Formula NotebookEvery number above, with the working shown. Check us.
Every number we publish, with the working shown. The formula, the same formula with this company’s actual figures put into it, the answer, and what it is for. Check us. That is the point.
PAT ÷ Net Worth27.01 ÷ 94.93What the company earned on the money shareholders have in it. The headline measure of return — and the one the DuPont section takes apart.
EBIT ÷ (Net Worth + Total Borrowings)44.00 ÷ (94.93 + 51.72) = 44.00 ÷ 146.65Return on ALL the capital in the business, borrowed as well as owned. Unlike ROE, it cannot be flattered by taking on debt.
EBITDA ÷ Revenue46.88 ÷ 349.43Operating profitability before the effects of debt, tax and depreciation. What the business earns from the act of trading.
Total Borrowings ÷ Net Worth51.72 ÷ 94.93How much the company has borrowed against what it owns. High is not automatically bad — ask whether the borrowing is being serviced comfortably.
EBIT ÷ Finance Cost44.00 ÷ 8.02How many times over operating profit covers the interest bill. Below about 2x, a meaningful share of what the business earns is going to lenders rather than owners.
(Trade Receivables ÷ Revenue) × 365(72.71 ÷ 349.43) × 365How long the company waits to be paid. Rising receivable days mean revenue is being booked faster than it is collected — which is where a great many accounting problems begin.
Inventory Days + Receivable Days − Payable Days97 + 76 − 66How long cash is tied up in the operating cycle before it comes back. The longer it is, the more working capital the business must fund.
Cash from Operations ÷ PAT38.06 ÷ 27.01Did the profit turn into cash? Profit is an opinion; cash is a fact. When this sits well below 1x for long, the two are drifting apart, and the filing is where you find out why.
(PAT − Cash from Operations) ÷ Total Assets(27.01 − 38.06) ÷ 206.13 = -11.05 ÷ 206.13The share of reported profit that exists on paper rather than in the bank. It is also the heaviest single term in the Beneish model, for good reason.
Price × Post-issue Shares₹150.00 × 62,031,834 sharesWhat the whole company is being valued at, if the issue prices at the top of the band.
Market Cap + Total Borrowings − Cash930.48 + 51.72 − 0.67What it would actually cost to buy the whole business: you take on its debt and you get its cash. This is the number a buyer cares about, and it is the reason a P/E on its own can mislead.
Enterprise Value ÷ EBITDA981.53 ÷ 46.88The multiple that includes debt. Two companies on the same P/E — one debt-free, one heavily borrowed — are not the same investment, and only this number tells you so.
Market Cap ÷ PAT930.48 ÷ 27.01The familiar multiple. Useful, but blind to debt — read it alongside EV/EBITDA, never instead of it.
Offer price ÷ weighted average cost of acquisition₹150.00 ÷ ₹2.90Every offer document must disclose the weighted average cost of acquisition for shares issued or transferred over the preceding one, eighteen and thirty-six months. Early capital takes real risk and a large multiple built over years is ordinary. A steep step-up inside a short window is the one that deserves a second look. What it means is yours to decide; the arithmetic is the filing’s own.
Growth needed to reach the peer multiple on earnings alone34.45x against a peer median of 14.53xThis is not a forecast and not a target. It is the price restated as a question: at this multiple, with the price unchanged, earnings would have to compound at this rate to arrive at what the filing’s own peer group trades on. Whether the business can do that is the argument — we are only stating what the argument is about.
EBIT × (1 − tax rate) ÷ (Net Worth + Debt − Cash)NOPAT ÷ Invested CapitalWhat the business earns on the capital actually at work in it. We do not compare this to a cost of capital: that would need a beta, an unlisted company has none, and inventing one would be theatre.
Latest full-year PAT ÷ market value₹27.01 cr ÷ ₹930.48 crThe P/E turned upside down: what each rupee of market value earns today. Set it against what you could earn elsewhere; the gap is what growth has to make up.
(Operating cash flow − capital expenditure) ÷ market value₹33.33 cr ÷ ₹930.48 crCash left after the company pays for its own investment, against the price of the whole company. Profit can be shaped by accounting choices; this is harder to shape.
P/E ÷ trailing PAT growth (%)34.45 ÷ 27.8%PEG was designed for FORWARD growth. This one uses TRAILING growth, because that is all a prospectus gives us — and the final year before an IPO is very often the best year the company will have for a while. A low PEG here may say more about the timing of the filing than about the price. We show it because it was asked for; we show the growth denominator beside it so it cannot mislead you quietly.
Workspace
The post-issue share count is stated as “[•]” in this filing until final pricing, so we derive it: profit after tax divided by earnings per share gives the pre-issue count, and the fresh issue divided by the offer price gives the new shares. Everything below rests on that derivation. It is close, not exact.
The numbers are already loaded. Move the offer price and watch every multiple move with it. Set your own growth and margin and see what they imply two years out. These are your assumptions, not our forecast — we have no view on what this company will earn, and the moment we published one we would be doing something we are not registered to do. What we can do is put the arithmetic in front of you and get out of the way.
Price defaults to the top of the band. Margin defaults to what the company actually reported in FY26.
Projections are arithmetic on the inputs you typed. They are not a forecast, not a recommendation, and not a view on whether this offer is worth taking. Educational only.
Institutional Alpha: DRHP Deep Dive
The global polymer compounding market stood at USD 75,526 million in 2025 and is expected to reach USD 109,801 million by 2031. The Indian polymer compounding market expanded from USD 5,967 million in 2019 to USD 9,934 million in 2025 and is projected to reach USD 16,507 million by 2031.
Phasing Out of PVC Compounding Business
The company is actively phasing out the manufacturing of PVC compounds, leading to low capacity utilization in PVC lines (11.79% in FY26), and shifting focus toward higher-margin PE and XLPE formulations.
Source: p.268Significant Related Party Purchases via Group Entity
The company purchased raw materials worth ₹ 32.35 crore (9.26% of procurement costs) in FY26 from group company Vinsul Makardi Limited, which operates in a competing/similar line of business without non-compete agreements.
Source: p.24, p.41Shareholding, Syndicate & Leadership
Leadership & Skin in the Game
Leadership: Karan Aggarwal
Litigation: 1 tax proceeding against Promoters involving ₹ 0.08 lakhs; 2 criminal proceedings against Directors (excluding Promoters) which are not quantifiable.
Peers & Valuation
| Company | P/E | P/B | RoE | Margin |
|---|---|---|---|---|
| Kingfa Science & Technology (India) Limited | 46.25 | — | 13.24 | — |
| DDev Plastiks Industries Limited | 12.97 | — | 19.92 | — |
| Plastiblends India Limited | 14.53 | — | 8.17 | — |
At the ₹150 upper band, the issue is priced at 25.0x earnings — a 72% premium to the peer median of 14.5x. This is the arithmetic of the price band against the peers the filing itself lists; it is not a view on whether the offer is worth taking.
Polymer Compounding Industry Metrics
The operating metrics that actually price this business — the ones a generic IPO page skips. Straight from the filing.
| Metric | Value | Detail |
|---|---|---|
| Global Polymer Compounding Market Size (2025) | 75,526 USD Million | Expected to reach USD 109,801 Million by 2031 (CAGR 6.4%) |
| Indian Polymer Compounding Market Size (2025) | 9,934 USD Million | Expected to reach USD 16,507 Million by 2031 (CAGR 9.0%) |
Source: p.175, p.235
🔍 Forensic Findings — What the Footnotes Say
Findings from across the filing — the notes, MD&A, related-party disclosures, contingent liabilities, CARO and litigation, alongside the risk section itself. Each carries where it was found, so you can see which were buried and which were disclosed. Findings marked derived are computed from the filed numbers against a stated rule, shown beside them.
The statutory auditor noted in CARO report that while the company has implemented an internal audit system under section 138, it is not commensurate with the size and nature of its business.
p.43046 shareholders holding 3,32,851 equity shares (including 2,61,881 bonus shares in suspense escrow) are untraceable or unresponsive.
p.107Pending tax demands under dispute amounting to ₹ 23.35 lakhs (Income Tax) and ₹ 50.77 lakhs (GST).
p.4301 tax proceeding against Promoters involving ₹ 0.08 lakhs; 2 criminal proceedings against Directors (excluding Promoters) which are not quantifiable.
p.288, p.309, p.322Short-term borrowings of ₹48.87 cr against cash of ₹0.67 cr. Debt that must be refinanced within a year is comfortable only while lenders stay comfortable.
rule: cash < 0.5x short-term debtCompany's Claims vs Reality
We stress-test each claim against the filing's own data.
Enlistments verified with Maharatna, Navratna, and Miniratna CPSEs as disclosed in RHP.
p.256Total capacity planned to increase from 35,251 MTPA to 87,301 MTPA across product lines.
p.123Proprietary SWOT — Company-Specific
Strengths
- Enlisted with prominent government agencies and CPSEs for specialized cable and coating compounds.
- Diversified product portfolio offering 127 grades across PE, XLPE, PVC, HFFR, and coating compounds.
- Long-standing customer relationships with high repeat business (~96.51% of revenue in FY26).
- PAN-India market presence supplying across 23 states and union territories.
Weaknesses
- High customer concentration with top 10 customers accounting for 66.81% of revenue in FY26.
- Dependence on raw material suppliers and volatility in polymer resin prices (LLDPE, HDPE).
Opportunities
- Growth in domestic wire & cable and oil & gas pipeline infrastructure driven by Jal Jeevan Mission, 5G rollout, and National Gas Grid.
- Expansion of installed capacity in Goa from 35,251 MTPA to 87,301 MTPA.
Threats (material, not boilerplate)
- Intense competition from organized and unorganized domestic players and low-cost imports. risk_section
Why it matters: May exert pricing pressure and compress operating margins.
Allotment Status
Check your allotment on the registrar's portal → Registrar: KFin Technologies
Allotment is decided by the registrar, not by us and not by the exchange. In an oversubscribed retail book, allotment is by lottery, so a large application does not improve your odds beyond one lot. If money stays blocked after the refund date, the mandate expiry (10 Dec 2026) is the date to raise with your bank.
Analyst Q&A: Burning Questions
Facts from the filing. No recommendation — that layer arrives once our Research Analyst registration is live.
What is the proposed expansion plan and timeline?
The company is expanding its Goa manufacturing capacity by 52,050 MTPA (from 35,251 MTPA to 87,301 MTPA) with a total estimated cost of ₹ 77.56 crore funded via fresh issue proceeds, to be implemented across FY27 and FY28.
p.121, p.123How much issue proceeds are allocated for working capital?
The company proposes to deploy ₹ 89.50 crore from the Net Proceeds towards funding working capital requirements in Fiscal 2027 (₹ 39.00 crore) and Fiscal 2028 (₹ 50.50 crore).
p.121, p.122Lock-in Expiry Calendar
Shares held before the IPO cannot be sold immediately; they unlock in tranches. When a tranche unlocks, more shares become eligible to trade. Retail investors are frequently caught unaware by these dates. The schedule below follows from the listing date; quantities are shown only where the filing discloses them.
- 03 Nov 2029Promoter Contribution (Minimum)3 years
An unlock means more shares may be sold — not that they will be, and not that the price will move. We state the dates; what you do with them is your call.
Educational, grounded entirely in the company's filings (DRHP/RHP). Not investment advice. FinMinutes does not provide buy/sell recommendations.
